# US 2012/0252009 A1 · Methods and Compositions for Enriching Either Target Polynucleotides or Non-Target Polynucleotides from a Mixture of Target and Non-Target Polynucleotides

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252009 A1
- Document ID: US20120252009A1
- Status: Published application
- Kind: A1
- Application number: 13/435,590
- Filed: 2012-03-30
- Published: 2012-10-04
- Earliest claimed: 2011-04-02
- Assignees: New England Biolabs, Inc.
- Inventors: George R. Feehery; Fiona Stewart; James McFarland; Sriharsa Pradhan
- Web page: https://patentgrep.com/patent/US20120252009A1

## CPC

- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Compositions and methods are provided for enriching non-target polynucleotides from a mixture of non-target and target polynucleotides where differences between the target polynucleotides and the non-target polynucleotides include the extent of modified bases that are present in a greater density in the target polynucleotides than in the non-target polynucleotides. This permits the target polynucleotides to be selectively and rapidly bound to an affinity matrix such as affinity protein-coated magnetic beads providing enrichment of the non-target polynucleotides in the supernatant. One use of this enrichment is to remove human genomic DNA from a mixture of DNAs obtained from human tissue samples to enrich for polynucleotides in a microbiome so as to characterize the microbiome by DNA sequencing.

## Claims

### Claim 1

A composition, comprising:
(a) a mixture of non-target and target polynucleotides, the polynucleotides in the mixture having a size in the range of 10-100 Kb;
(b) a matrix coated with a protein or a polypeptide domain to form an affinity matrix that is capable of selectively binding the target polynucleotides containing modified bases but not the non-target polynucleotides; and
(c) a buffer containing effective amounts of a salt and a non-ionic detergent.

### Claim 2 (depends on 1)

A composition, according to claim 1, wherein the effective amount of salt is 10 mM-800 mM.

### Claim 3 (depends on 1)

A composition according to claim 1, wherein the modified bases in the target polynucleotides occur at a frequency of at least 1 modified base in 200 bases.

### Claim 4 (depends on 1)

A method for enriching polynucleotides from a mixture, comprising:
(a) obtaining a composition according to claim 1;
(b) permitting binding of the target polynucleotides to the affinity matrix; and
(c) obtaining an enriched preparation of non-target polynucleotides in a supernatant fraction.

### Claim 5 (depends on 4)

A method according to claim 4, wherein the non-target polynucleotides in the supernatant are at least 90% of the non-target polynucleotides in the mixture prior to enrichment.

### Claim 6 (depends on 4)

A method according to claim 4, wherein the target polynucleotides in the supernatant comprise no more than 10% of the target polynucleotides in the mixture prior to enrichment.

### Claim 7 (depends on 4)

A method according to claim 4, wherein the modified bases are methylated cytosines.

### Claim 8 (depends on 4)

A method according to claim 4, wherein the mixture of polynucleotides prior to enrichment is obtained from a biological sample and comprises prokaryotic and mammalian genomic DNA wherein the mixture comprises at least 50% mammalian genomic DNA.

### Claim 9 (depends on 4)

A method according to claim 4, further comprising: analyzing the non-target polynucleotides in the supernatant by sequencing, cloning or amplification to determine a genomic identity for the non-target polynucleotides.

### Claim 10 (depends on 4)

A method according to claim 4, wherein the affinity matrix comprises a methyl-binding domain (MBD) selected from the group consisting of UHRF1(SRA), CXX1, DNMT1, MBD or methyl-binding variants thereof.

### Claim 11 (depends on 4)

A method according to claim 4, wherein the affinity matrix comprises magnetic beads.

### Claim 12 (depends on 11)

A method according to claim 11, wherein the magnetic beads are coated with protein A bound to MBD2a-Fc

### Claim 13 (depends on 4)

A method according to claim 4, wherein the salt is NaCl in a concentration range of 10 mM-800 mM.

### Claim 14 (depends on 1)

A method of enhancing separation of polynucleotides containing methylated cytosine adjacent to a guanine (CpG), from unmethylated polynucleotides; comprising:
(a) providing a composition according to claim 1 wherein the modified bases are methylated CpGs;
(b) permitting the CpG methylated polynucleotides to bind to the affinity matrix to form a product that is immobilized on the matrix; and
(c) performing amplification and/or sequencing of at least one of the bound polynucleotide or the unbound polynucleotide.

### Claim 15 (depends on 14)

A method according to claim 14, wherein the mixture of methylated and unmethylated polynucleotides comprise fragments from one or more bacterial genomes and one or more mammalian genomes.

### Claim 16 (depends on 14)

A method according to claim 14, wherein the matrix is a magnetic bead.

### Claim 17 (depends on 14)

A method according to claim 14, wherein the methylated nucleoside-binding protein is selected from UHRF1(SRA), CXX1, DNMT1, MBD or methyl-binding variants thereof.

### Claim 18 (depends on 14)

A method according to claim 14, wherein the effective amount of salt is in the range of 100 mM-800 mM NaCl.

### Claim 19

A composition, comprising: a target DNA containing methylated CpG, the target DNA being capable of binding to an MBD beads in a buffer; a non-target DNA that cannot readily bind to the MBD beads in the buffer, the buffer containing 100 mM-800 mM NaCl and a non-ionic detergent.

### Claim 20 (depends on 19)

A composition according to claim 19, wherein the target DNA and the non-target DNA having a size in the range of 10-100 kb.
